BOLDEN THERAPEUTICS
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
BOLDEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Providence, Rhode Island, United States
Country:
United States
Website Url:
http://www.boldentherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
997.5 K USD
Technology used in webpage:
SPF Euro Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator GoDaddy Email
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - Bolden Therapeutics
National Institute on Aging
National Institute on Aging investment in Grant - Bolden Therapeutics
Official Site Inspections
http://www.boldentherapeutics.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.6 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Bolden Therapeutics"
Bolden Therapeutics
A bold new approach. Bolden Therapeutics is developing first-in-class therapeutics to increase neurogenesis (the formation of new brain cells) and improve outcomes in neurological …See details»
Bolden Therapeutics - Crunchbase Company Profile & Funding
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.See details»
Bolden Therapeutics Company Profile | Management and
Www.boldentherapeutics.com Bolden Therapeutics Profile and History Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system …See details»
Bolden Therapeutics Company Profile 2024: Valuation, Funding ...
Bolden Therapeutics General Information Description. Operator of a biotechnology company intended to improve the lives of patients suffering from neurodegeneration. The company …See details»
Bolden Therapeutics - LinkedIn
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.See details»
Bolden Therapeutics - BIO International Convention | BIO
Jun 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Bolden Therapeutics Receives $406,466 SBIR Grant from The …
September 16, 2022 — CAMBRIDGE, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of …See details»
Bolden Therapeutics - VentureRadar
Similar Companies: OPHIDION, INC. USA Privately Held Ophidion, Inc. is an early-stage central nervous system (CNS) biopharmaceutical company leveraging its unique proprietary carrier …See details»
Bolden Therapeutics Receives $500,000 Small Business Grant from …
September 27, 2021 — PROVIDENCE, RI & CAMBRIDGE, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for …See details»
Bolden Therapeutics - Overview, News & Similar companies
Jun 7, 2023 www.boldentherapeutics.com. Revenue <$5 Million. Industry Business Services General Business Services . Most Recent Scoops. Jan 17 2024. Funding. Jun 7 2023. Event. …See details»
BOLDEN THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT …
Jan 17, 2024 Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system …See details»
BOLDEN THERAPEUTICS RECEIVES $406,466 SBIR GRANT FROM …
Sep 16, 2022 Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases. The company's scientific co-founders, …See details»
Bolden Therapeutics - VentureRadar
Website: https://boldentherapeutics.com/ Develops groundbreaking therapeutics promoting neurogenesis to treat CNS illnesses, using antisense oligonucleotides for ...See details»
Bolden Therapeutics Receives $497,500 SBIR Grant from The …
June 29, 2022 — CAMBRIDGE, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of …See details»
Bolden Therapeutics Closes $1.5M in Pre-Seed Convertible Note
Jan 22, 2024 Bolden Th erapeutics, Inc., a Providence, R.I.-based biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of …See details»
Bolden Therapeutics pursues pharmaceutical research to combat ...
Apr 25, 2022 Bolden Therapeutics is a biotechnology company that develops therapeutics to promote the birth of new neurons in the adult brain for potential treatment of neurological …See details»
Bolden Therapeutics Announces Financing to Support …
PROVIDENCE, RI. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system …See details»
Bolden Announces $1.5M Pre-Seed Financing – Slater Technology …
Jan 17, 2024 Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis. Providence, R.I. – January 17, 2024 – Bolden Therapeutics, Inc., a biotechnology company …See details»
BOLDEN THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT …
PROVIDENCE, R.I., Jan. 17, 2024 /PRNewswire/ -- Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential …See details»
Bolden Therapeutics to Present at the 3
PROVIDENCE, RI and BOSTON, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of …See details»